Mannkind (MNKD) Research & Development (2010 - 2026)
Mannkind's (MNKD) quarterly Research & Development came in at $17.2 million in Q1 2026, up 56.33% year-on-year from $11.0 million in Q1 2025, and down 37.54% on a QoQ basis from $27.6 million in Q4 2025.
Mannkind (MNKD) Research & Development (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Research & Development data on file, last reported at $17.2 million in Q1 2026.
- On a quarterly basis, Research & Development rose 56.33% year-over-year to $17.2 million in Q1 2026; TTM through Mar 2026 was $72.6 million, a 54.7% increase from a year earlier, with the FY2025 full-year figure at $66.3 million, up 44.57% from the prior year.
- Research & Development for Q1 2026 stood at $17.2 million, down from $27.6 million in the prior quarter.
- Over the last five years, Research & Development for MNKD reached as high as $27.6 million in Q4 2025 and fell as low as $3.5 million in Q1 2022.
- Historically, Research & Development has averaged $10.6 million across 5 years, with a median of $10.0 million in 2024.
- On a YoY basis, Research & Development climbed as much as 147.69% in 2025 and fell as far as 8.8% in 2025.
- Year by year, Research & Development stood at $7.2 million in 2022, then gained by 29.07% to $9.2 million in 2023, then advanced by 20.59% to $11.1 million in 2024, then surged by 147.69% to $27.6 million in 2025, then slumped by 37.54% to $17.2 million in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $17.2 million in Q1 2026, $27.6 million in Q4 2025, and $14.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | 17.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.23 Mn |
| Dec 31, 2025 | 27.59 Mn |
| Sep 30, 2025 | 14.06 Mn |
| Jun 30, 2025 | 13.68 Mn |
| Mar 31, 2025 | 11.02 Mn |
| Dec 31, 2024 | 11.14 Mn |
| Sep 30, 2024 | 12.93 Mn |
| Jun 30, 2024 | 11.82 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Dec 31, 2023 | 9.24 Mn |
| Sep 30, 2023 | 9.99 Mn |
| Jun 30, 2023 | 6.45 Mn |
| Mar 31, 2023 | 5.61 Mn |
| Dec 31, 2022 | 7.16 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 4.89 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.89 Mn |
| Sep 30, 2021 | 3.66 Mn |
| Jun 30, 2021 | 2.33 Mn |